Cargando…

BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma

Background: Bromodomain-containing protein 7 (BRD7) is identified as a transcriptional regulator and plays an important role in the development and progression of various tumors. Our previous study demonstrated that BRD7 acts as a potential tumor suppressor in hepatocellular carcinoma (HCC). However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chang-Long, Mo, Hua-Qian, Jiang, Yan-Hui, Zhao, Xiao-Hui, Ma, Shuang, You, Kai-Yun, Pan, Yue, Liu, Yi-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847651/ https://www.ncbi.nlm.nih.gov/pubmed/33531996 http://dx.doi.org/10.7150/jca.50293

Ejemplares similares

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma
por: Chen, Chang-Long, et al.
Publicado: (2016)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild-type P53
por: Luo, Yanwei, et al.
Publicado: (2022)

Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
por: Zhou, Julie Xia, et al.
Publicado: (2022)

BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2018)

Emerging Roles of BRD7 in Pathophysiology
por: Park, Sang Won, et al.
Publicado: (2020)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
por: Liu, Huaying, et al.
Publicado: (2008)

The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
por: Zhang, Zili, et al.
Publicado: (2020)

Retraction Note: BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer
por: Niu, Weihong, et al.
Publicado: (2019)

DDX55 promotes hepatocellular carcinoma progression by interacting with BRD4 and participating in exosome‐mediated cell‐cell communication
por: Yu, Bin, et al.
Publicado: (2022)

BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma
por: Chen, Yi-Ru, et al.
Publicado: (2020)

Unexpected BrdU inhibition on astrocyte-to-neuron conversion
por: Wang, Tao, et al.
Publicado: (2021)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

BRD4: An emerging prospective therapeutic target in glioma
por: Yang, Hua, et al.
Publicado: (2021)

High level of BRD4 promotes non-small cell lung cancer progression
por: Liao, Yun-Fei, et al.
Publicado: (2016)

BRD7 deficiency leads to the development of obesity and hyperglycemia
por: Lee, Junsik M., et al.
Publicado: (2019)

The role of BRD7 in embryo development and glucose metabolism
por: Kim, Yoo, et al.
Publicado: (2016)

Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth
por: Zhu, Hua, et al.
Publicado: (2017)

Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma
por: Gao, Yang, et al.
Publicado: (2022)

BRD4-mediated repression of p53 is a target for combination therapy in AML
por: Latif, Anne-Louise, et al.
Publicado: (2021)

Knockout of BRD7 results in impaired spermatogenesis and male infertility
por: Wang, Heran, et al.
Publicado: (2016)

BRD4 inhibition for the treatment of pathological organ fibrosis
por: Stratton, Matthew S., et al.
Publicado: (2017)

Inhibiting BRD4 to generate BETter T cell memory
por: Kasmani, Moujtaba Y., et al.
Publicado: (2021)

Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma
por: Hu, Kaishun, et al.
Publicado: (2014)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes
por: Sun, Xiaohui, et al.
Publicado: (2021)

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
por: Liu, Huaying, et al.
Publicado: (2008)

BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma
por: Gao, Yushun, et al.
Publicado: (2016)

BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma
por: Li, Mengna, et al.
Publicado: (2023)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in Arabidopsis
por: Jarończyk, Kamila, et al.
Publicado: (2021)

BRD4 Inhibitor Inhibits Colorectal Cancer Growth and Metastasis
por: Hu, Yuan, et al.
Publicado: (2015)

BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

FOXN4 Inhibits Breast Cancer Progression By Direct Activation Of P53
por: Ye, Hui, et al.
Publicado: (2020)

BRD7 mediates hyperglycaemia‐induced myocardial apoptosis via endoplasmic reticulum stress signalling pathway
por: Wang, Xiao‐meng, et al.
Publicado: (2016)

Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis
por: An, Jun, et al.
Publicado: (2017)

BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer
por: Zhao, Ran, et al.
Publicado: (2021)

Regulation of programmed cell death by Brd4
por: Hu, Jinfeng, et al.
Publicado: (2022)

Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4
por: Tang, Hailin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0csuq47k7k7e7sr0lmoh877mu4